07 September 2018
A new report by visiongain forecasts the world pharmaceutical anti-counterfeiting technology market will reach $6.5bn in 2020. That revenue prediction and others appear in Pharmaceutical Anti-Counterfeiting Technologies Market Forecast 2016-2026, published in April 2016. Visiongain is a business information publisher and consultancy in London, UK.
The analysis predicts the global pharmaceutical anti-counterfeiting technologies market will continue to grow at a CAGR of 13.6% from 2014-2020, driven by the barcode and RFID submarkets. In 2015, the barcode submarket held a higher market share than the RFID submarket. However, the RFID submarket will become the leading submarket in 2017.
Demand for the market will be fuelled by an increasing prevalence of illegal counterfeiting incidents. Pharmaceutical companies will increasingly identify the need to protect their intellectual property and brand integrity by marginalising the rise in counterfeit activity through the use of technology.
Robert King, a pharmaceutical and healthcare industry analyst in visiongain, said:
“The introduction of tougher criminal penalties for counterfeiters coupled with government involvement demanding e-pedigrees on all pharmaceutical products will help to expand the anti-counterfeiting technologies market. The increasingly global pharmaceutical supply chain will also act as a catalyst for growth in this market. China and India, for example, are among the largest exporters of pharma products; therefore growth in the anti-counterfeiting technologies market of these two big economies will boost the global market.
To implement anti-counterfeiting technologies on a global scale there must be cohesion between different national regulatory authorities. Cooperation between countries on an international level must improve – many are now working towards standardisation”.
This report investigates commercial trends and revenues of the pharmaceutical anti-counterfeiting technology market from 2016 to 2026, as well as including data from 2014/2015. This report discusses sales potentials of:
• The main submarkets of pharmaceutical anti-counterfeiting technology:
• 8 leading national markets:
This report qualitatively discusses:
• 15 anti-counterfeiting technology companies (including financial information) such as:
o Avery Dennison
o Multi Packaging Solutions
• The current and incoming legislation on a national market scale for pharmaceutical anti-counterfeiting technology including:
o The US
o The EU
• Strengths, weaknesses, opportunities and threats of the pharmaceutical anti-counterfeiting market.
The increasing rates of patent expiry lead to a counter-strategy of switching companies from Rx to OTC. In the US, according to the Consumer Healthcare Products Association, approximately 106 ingredients and dosage strengths have undergone a change from Rx to OTC to around 700 OTC products on the market.
23 September 2020
. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.
16 September 2020
Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.
14 September 2020
The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.